Keymed Biosciences Inc. logo

Keymed Biosciences Inc.

HKEX:2162.HK

Overview | Financials
Company Name Keymed Biosciences Inc.
Symbol 2162.HK
Currency HKD
Price 43.55
Market Cap 12,002,380,000
Dividend Yield 0%
52-week-range 26.6 - 64.45
Industry Biotechnology
Sector Healthcare
CEO Dr. Bo Chen
Website https://www.keymedbio.com

An error occurred while fetching data.

About Keymed Biosciences Inc.

Keymed Biosciences Inc., a biotechnology company, engages in the research and development of biological therapies for the treatment of autoimmunity and oncology diseases. Its lead product candidate is CM310 for the treatment of moderate to severe atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), and chronic obstructive pulmonary

Related Stocks

CK Life Sciences Int'l., (Holdings) Inc. logo

CK Life Sciences Int'l., (Holdings) Inc.

0775.HK

0.46 HKD

Brii Biosciences Limited logo

Brii Biosciences Limited

2137.HK

1.09 HKD

Medlive Technology Co., Ltd. logo

Medlive Technology Co., Ltd.

2192.HK

8.85 HKD

SciClone Pharmaceuticals (Holdings) Limited logo

SciClone Pharmaceuticals (Holdings) Limited

6600.HK

18.72 HKD

Everest Medicines Limited logo

Everest Medicines Limited

1952.HK

33.3 HKD

CARsgen Therapeutics Holdings Limited logo

CARsgen Therapeutics Holdings Limited

2171.HK

4.79 HKD

China Isotope & Radiation Corporation logo

China Isotope & Radiation Corporation

1763.HK

11.58 HKD

Jacobio Pharmaceuticals Group Co., Ltd. logo

Jacobio Pharmaceuticals Group Co., Ltd.

1167.HK

1.82 HKD

Beijing Chunlizhengda Medical Instruments Co., Ltd. logo

Beijing Chunlizhengda Medical Instruments Co., Ltd.

1858.HK

12.7 HKD

Alphamab Oncology logo

Alphamab Oncology

9966.HK

3.87 HKD

Financials

Numbers are in millions USD

Numbers are in millions USD